FR2646606B1 - Retrovirus hautement cytopathogenique hiv-ndk. fragment d'adn de ce retrovirus, procede de preparation d'une proteine et/ou enzyme de ce virus et leurs utilisations - Google Patents

Retrovirus hautement cytopathogenique hiv-ndk. fragment d'adn de ce retrovirus, procede de preparation d'une proteine et/ou enzyme de ce virus et leurs utilisations

Info

Publication number
FR2646606B1
FR2646606B1 FR898905914A FR8905914A FR2646606B1 FR 2646606 B1 FR2646606 B1 FR 2646606B1 FR 898905914 A FR898905914 A FR 898905914A FR 8905914 A FR8905914 A FR 8905914A FR 2646606 B1 FR2646606 B1 FR 2646606B1
Authority
FR
France
Prior art keywords
retrovirus
ndk
cytopathogenic
hiv
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR898905914A
Other languages
English (en)
Other versions
FR2646606A1 (fr
Inventor
Francoise Barre-Sinoussi
Jean-Claude Chermann
Christian Devaux
Francoise Rey
Josephine Sire
Bruno Spire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to FR898905914A priority Critical patent/FR2646606B1/fr
Priority to CA002054720A priority patent/CA2054720A1/fr
Priority to JP2507972A priority patent/JPH04507042A/ja
Priority to PCT/FR1990/000312 priority patent/WO1990013630A1/fr
Priority to EP19900908235 priority patent/EP0471028A1/fr
Publication of FR2646606A1 publication Critical patent/FR2646606A1/fr
Application granted granted Critical
Publication of FR2646606B1 publication Critical patent/FR2646606B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
FR898905914A 1989-05-03 1989-05-03 Retrovirus hautement cytopathogenique hiv-ndk. fragment d'adn de ce retrovirus, procede de preparation d'une proteine et/ou enzyme de ce virus et leurs utilisations Expired - Fee Related FR2646606B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR898905914A FR2646606B1 (fr) 1989-05-03 1989-05-03 Retrovirus hautement cytopathogenique hiv-ndk. fragment d'adn de ce retrovirus, procede de preparation d'une proteine et/ou enzyme de ce virus et leurs utilisations
CA002054720A CA2054720A1 (fr) 1989-05-03 1990-05-02 Retrovirus hautement cytopathogenique hiv-ndk, fragments d'adn de ce retrovirus, procede de preparation d'une proteine et/ou enzyme de ce virus et leurs utilisations
JP2507972A JPH04507042A (ja) 1989-05-03 1990-05-02 高度の細胞病原性ｈｉｖ―ｎｄｋレトロウイルス、このレトロウイルスのｄｎａフラグメント、このウイルスのタンパク質および／または酵素の調製法、およびその利用
PCT/FR1990/000312 WO1990013630A1 (fr) 1989-05-03 1990-05-02 Retrovirus hautement cytopathogenique hiv-ndk, fragments d'adn de ce retrovirus, procede de preparation d'une proteine et/ou enzyme de ce virus et leurs utilisations
EP19900908235 EP0471028A1 (fr) 1989-05-03 1990-05-02 Retrovirus hautement cytopathogenique hiv-ndk, fragments d'adn de ce retrovirus, procede de preparation d'une proteine et/ou enzyme de ce virus et leurs utilisations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR898905914A FR2646606B1 (fr) 1989-05-03 1989-05-03 Retrovirus hautement cytopathogenique hiv-ndk. fragment d'adn de ce retrovirus, procede de preparation d'une proteine et/ou enzyme de ce virus et leurs utilisations

Publications (2)

Publication Number Publication Date
FR2646606A1 FR2646606A1 (fr) 1990-11-09
FR2646606B1 true FR2646606B1 (fr) 1994-06-17

Family

ID=9381408

Family Applications (1)

Application Number Title Priority Date Filing Date
FR898905914A Expired - Fee Related FR2646606B1 (fr) 1989-05-03 1989-05-03 Retrovirus hautement cytopathogenique hiv-ndk. fragment d'adn de ce retrovirus, procede de preparation d'une proteine et/ou enzyme de ce virus et leurs utilisations

Country Status (5)

Country Link
EP (1) EP0471028A1 (fr)
JP (1) JPH04507042A (fr)
CA (1) CA2054720A1 (fr)
FR (1) FR2646606B1 (fr)
WO (1) WO1990013630A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
FR2730493B1 (fr) * 1995-02-09 1997-04-18 Pasteur Institut Polypeptides de glycoproteine transmembranaire d'enveloppe du retrovirus humain du type hiv-1 et polypeptides presentant avec eux une parente immunologique
AU4663297A (en) * 1996-10-04 1998-04-24 Government Of The United States Of America, The Inhibition of hiv replication using soluble tat peptide analogs
US6686333B1 (en) * 1996-10-04 2004-02-03 The United States Of America As Represented By The Department Of Health And Human Resources Inhibition of HIV replication using soluble Tat peptide analogs
CN104039968B (zh) * 2011-09-26 2018-10-26 赛拉福柯蒂斯公司 非b亚型gag蛋白在慢病毒包装中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030714A (en) * 1986-06-23 1991-07-09 Institut Pasteur Variant of LAV viruses

Also Published As

Publication number Publication date
FR2646606A1 (fr) 1990-11-09
JPH04507042A (ja) 1992-12-10
WO1990013630A1 (fr) 1990-11-15
EP0471028A1 (fr) 1992-02-19
CA2054720A1 (fr) 1990-11-04

Similar Documents

Publication Publication Date Title
DE3586313D1 (de) Konjugate von pharmazeutisch nuetzlichen proteinen.
DE3587864D1 (de) Rekombinant-dns-moleküle.
EP0179139A4 (fr) Analyse, vaccin et immunogene du virus associe a la leucemie.
DE3750619D1 (de) System zur Abgabe von Arzneistoffen.
DE3584349D1 (de) Lhrh-analoga, welche die anti-lhrh-antikoerper stimulieren und diese enthaltende vakzine.
NO872075L (no) Herbicid-toleranse-kodende dna.
CA2011878A1 (fr) Regions immunogenes sur la proteine e7 du papillomavirus humain de type 16
NO891818D0 (no) T4-reseptor-protein, relaterte dna-sekvenser samt fremstilling derav.
ATE219838T1 (de) Verwendung von funktionellen derivaten des interzellulär-adhäsions-moleküls icam-1 in einer antivirus-therapie
IT8819077A0 (it) Processo per la preparazione di 1,2 difluoroetano e di 1,1,2trifluoroetano.
DE69736840D1 (de) Synthese von nukleosiden und polynukleotiden
OA09389A (fr) "Système de construction de bâtiment".
MA26608A1 (fr) Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque.
NO875358L (no) 6-benzoksazinyl- og 6-benzotiazinyl-2,3,4,5-tetrahydropyridazin-3-oner og fremgangsmaate for deres fremstilling.
DE3787564D1 (de) Kationische asphaltemulsionen.
FR2687687B1 (fr) Procede pour mesurer la taille de fragments d'adn.
DE68921229D1 (de) Prozess zur Behandlung von unlöslichem heterogenem Fusionsprotein.
FR2646606B1 (fr) Retrovirus hautement cytopathogenique hiv-ndk. fragment d'adn de ce retrovirus, procede de preparation d'une proteine et/ou enzyme de ce virus et leurs utilisations
FR2604438B1 (fr) Nouveaux conjugues de couplage entre des sequences d'arn ou d'adn et une proteine, leur procede de preparation et leur application biologique
FI101797B1 (fi) STLV-III-virukseen liittyvät polypeptidit, diagnostiset järjestelmät ja määritysmenetelmät
MA21100A1 (fr) Procede de preparation d'uree .
NO871038D0 (no) Dna-fragment.
FR2644176B1 (fr) Retrovirus viscpz infectant naturellement le chimpanze, fragments d'adn de ce retrovirus, procede de preparation d'une proteine et/ou d'une enzyme de ce virus et leurs utilisations
ATE214708T1 (de) Kationische mittel zur transfektion von nukleinsäuren
FR2594169B1 (fr) Systeme de protection de produits de valeur notamment de fonds et/ou de produits bancaires.

Legal Events

Date Code Title Description
ST Notification of lapse